<!DOCTYPE HTML>
<!-- NewPage -->
<html lang="en">
<head>
<!-- Generated by javadoc (15) on Sun Aug 04 17:16:16 EDT 2024 -->
<title>org.drip.sample.xvabasel</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta name="dc.created" content="2024-08-04">
<meta name="description" content="declaration: package: org.drip.sample.xvabasel">
<meta name="generator" content="javadoc/PackageWriterImpl">
<link rel="stylesheet" type="text/css" href="../../../../stylesheet.css" title="Style">
<link rel="stylesheet" type="text/css" href="../../../../script-dir/jquery-ui.min.css" title="Style">
<link rel="stylesheet" type="text/css" href="../../../../jquery-ui.overrides.css" title="Style">
<script type="text/javascript" src="../../../../script.js"></script>
<script type="text/javascript" src="../../../../script-dir/jquery-3.5.1.min.js"></script>
<script type="text/javascript" src="../../../../script-dir/jquery-ui.min.js"></script>
</head>
<body class="package-declaration-page">
<script type="text/javascript">var pathtoroot = "../../../../";
loadScripts(document, 'script');</script>
<noscript>
<div>JavaScript is disabled on your browser.</div>
</noscript>
<div class="flex-box">
<header role="banner" class="flex-header">
<nav role="navigation">
<!-- ========= START OF TOP NAVBAR ======= -->
<div class="top-nav" id="navbar.top">
<div class="skip-nav"><a href="#skip.navbar.top" title="Skip navigation links">Skip navigation links</a></div>
<ul id="navbar.top.firstrow" class="nav-list" title="Navigation">
<li><a href="../../../../index.html">Overview</a></li>
<li class="nav-bar-cell1-rev">Package</li>
<li>Class</li>
<li><a href="package-use.html">Use</a></li>
<li><a href="package-tree.html">Tree</a></li>
<li><a href="../../../../deprecated-list.html">Deprecated</a></li>
<li><a href="../../../../index-files/index-1.html">Index</a></li>
<li><a href="../../../../help-doc.html">Help</a></li>
</ul>
</div>
<div class="sub-nav">
<div class="nav-list-search"><label for="search">SEARCH:</label>
<input type="text" id="search" value="search" disabled="disabled">
<input type="reset" id="reset" value="reset" disabled="disabled">
</div>
</div>
<!-- ========= END OF TOP NAVBAR ========= -->
<span class="skip-nav" id="skip.navbar.top">
<!--   -->
</span></nav>
</header>
<div class="flex-content">
<main role="main">
<div class="header">
<h1 title="Package" class="title">Package&nbsp;org.drip.sample.xvabasel</h1>
</div>
<section class="package-description" id="package.description">
<div class="block">Basel XVA Accounting Metrics Scheme</div>
<dl class="notes">
<dt>Author:</dt>
<dd>Lakshmi Krishnamurthy</dd>
</dl>
</section>
<section class="summary">
<ul class="summary-list">
<li>
<div class="type-summary">
<table class="summary-table">
<caption><span>Class Summary</span></caption>
<thead>
<tr>
<th class="col-first" scope="col">Class</th>
<th class="col-last" scope="col">Description</th>
</tr>
</thead>
<tbody>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedCollateralNeutral.html" title="class in org.drip.sample.xvabasel">CollateralizedCollateralNeutral</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedCollateralNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedCollateralNeutralStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedCollateralNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedCollateralNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedCollateralPayable.html" title="class in org.drip.sample.xvabasel">CollateralizedCollateralPayable</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedCollateralPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedCollateralPayableStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedCollateralPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedCollateralPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedCollateralReceivable.html" title="class in org.drip.sample.xvabasel">CollateralizedCollateralReceivable</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedCollateralReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
        Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
        Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedCollateralReceivableStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedCollateralReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedCollateralReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to
        a Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and
        FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedFundingNeutral.html" title="class in org.drip.sample.xvabasel">CollateralizedFundingNeutral</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedFundingNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedFundingNeutralStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedFundingNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedFundingNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
        Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
        Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedFundingPayable.html" title="class in org.drip.sample.xvabasel">CollateralizedFundingPayable</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedFundingPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedFundingPayableStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedFundingPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedFundingPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
        Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
        Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedFundingReceivable.html" title="class in org.drip.sample.xvabasel">CollateralizedFundingReceivable</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedFundingReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedFundingReceivableStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedFundingReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedFundingReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedNettingNeutral.html" title="class in org.drip.sample.xvabasel">CollateralizedNettingNeutral</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedNettingNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedNettingNeutralStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedNettingNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedNettingNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedNettingPayable.html" title="class in org.drip.sample.xvabasel">CollateralizedNettingPayable</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedNettingPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedNettingPayableStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedNettingPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedNettingPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="CollateralizedNettingReceivable.html" title="class in org.drip.sample.xvabasel">CollateralizedNettingReceivable</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedNettingReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="CollateralizedNettingReceivableStochastic.html" title="class in org.drip.sample.xvabasel">CollateralizedNettingReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>CollateralizedNettingReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedCollateralNeutral.html" title="class in org.drip.sample.xvabasel">UncollateralizedCollateralNeutral</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedCollateralNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedCollateralNeutralStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedCollateralNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedCollateralNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedCollateralPayable.html" title="class in org.drip.sample.xvabasel">UncollateralizedCollateralPayable</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedCollateralPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedCollateralPayableStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedCollateralPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedCollateralPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedCollateralReceivable.html" title="class in org.drip.sample.xvabasel">UncollateralizedCollateralReceivable</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedCollateralReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
        Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
        Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedCollateralReceivableStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedCollateralReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedCollateralReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact
        to a Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and
        FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedFundingNeutral.html" title="class in org.drip.sample.xvabasel">UncollateralizedFundingNeutral</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedFundingNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedFundingNeutralStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedFundingNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedFundingNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedFundingPayable.html" title="class in org.drip.sample.xvabasel">UncollateralizedFundingPayable</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedFundingPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedFundingPayableStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedFundingPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedFundingPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedFundingReceivable.html" title="class in org.drip.sample.xvabasel">UncollateralizedFundingReceivable</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedFundingReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedFundingReceivableStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedFundingReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedFundingReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedNettingNeutral.html" title="class in org.drip.sample.xvabasel">UncollateralizedNettingNeutral</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedNettingNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedNettingNeutralStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedNettingNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedNettingNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedNettingPayable.html" title="class in org.drip.sample.xvabasel">UncollateralizedNettingPayable</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedNettingPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedNettingPayableStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedNettingPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedNettingPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="UncollateralizedNettingReceivable.html" title="class in org.drip.sample.xvabasel">UncollateralizedNettingReceivable</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedNettingReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="UncollateralizedNettingReceivableStochastic.html" title="class in org.drip.sample.xvabasel">UncollateralizedNettingReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>UncollateralizedNettingReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdCollateralNeutral.html" title="class in org.drip.sample.xvabasel">ZeroThresholdCollateralNeutral</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdCollateralNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdCollateralNeutralStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdCollateralNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdCollateralNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdCollateralPayable.html" title="class in org.drip.sample.xvabasel">ZeroThresholdCollateralPayable</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdCollateralPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdCollateralPayableStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdCollateralPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdCollateralPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdCollateralReceivable.html" title="class in org.drip.sample.xvabasel">ZeroThresholdCollateralReceivable</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdCollateralReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio
        of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdCollateralReceivableStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdCollateralReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdCollateralReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdFundingNeutral.html" title="class in org.drip.sample.xvabasel">ZeroThresholdFundingNeutral</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdFundingNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of 10
  Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdFundingNeutralStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdFundingNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdFundingNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdFundingPayable.html" title="class in org.drip.sample.xvabasel">ZeroThresholdFundingPayable</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdFundingPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of 10
  Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdFundingPayableStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdFundingPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdFundingPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdFundingReceivable.html" title="class in org.drip.sample.xvabasel">ZeroThresholdFundingReceivable</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdFundingReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdFundingReceivableStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdFundingReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdFundingReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdNettingNeutral.html" title="class in org.drip.sample.xvabasel">ZeroThresholdNettingNeutral</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdNettingNeutral</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of 10
  Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdNettingNeutralStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdNettingNeutralStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdNettingNeutralStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdNettingPayable.html" title="class in org.drip.sample.xvabasel">ZeroThresholdNettingPayable</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdNettingPayable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of 10
  Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdNettingPayableStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdNettingPayableStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdNettingPayableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
<tr class="alt-color">
<th class="col-first" scope="row"><a href="ZeroThresholdNettingReceivable.html" title="class in org.drip.sample.xvabasel">ZeroThresholdNettingReceivable</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdNettingReceivable</i> examines the Basel BCBS 2012 OTC Accounting Impact to a Portfolio of
        10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA Schemes.</div>
</td>
</tr>
<tr class="row-color">
<th class="col-first" scope="row"><a href="ZeroThresholdNettingReceivableStochastic.html" title="class in org.drip.sample.xvabasel">ZeroThresholdNettingReceivableStochastic</a></th>
<td class="col-last">
<div class="block"><i>ZeroThresholdNettingReceivableStochastic</i> examines the Basel BCBS 2012 OTC Accounting Impact to a
  Portfolio of 10 Swaps resulting from the Addition of a New Swap - Comparison via both FVA/FDA and FCA/FBA
  Schemes.</div>
</td>
</tr>
</tbody>
</table>
</div>
</li>
</ul>
</section>
</main>
<footer role="contentinfo">
<nav role="navigation">
<!-- ======= START OF BOTTOM NAVBAR ====== -->
<div class="bottom-nav" id="navbar.bottom">
<div class="skip-nav"><a href="#skip.navbar.bottom" title="Skip navigation links">Skip navigation links</a></div>
<ul id="navbar.bottom.firstrow" class="nav-list" title="Navigation">
<li><a href="../../../../index.html">Overview</a></li>
<li class="nav-bar-cell1-rev">Package</li>
<li>Class</li>
<li><a href="package-use.html">Use</a></li>
<li><a href="package-tree.html">Tree</a></li>
<li><a href="../../../../deprecated-list.html">Deprecated</a></li>
<li><a href="../../../../index-files/index-1.html">Index</a></li>
<li><a href="../../../../help-doc.html">Help</a></li>
</ul>
</div>
<!-- ======== END OF BOTTOM NAVBAR ======= -->
<span class="skip-nav" id="skip.navbar.bottom">
<!--   -->
</span></nav>
</footer>
</div>
</div>
</body>
</html>
